- Herpes zoster vaccine in Korea
-
Choi WS
- KMID: 2167718
- Clin Exp Vaccine Res.
- 2013 Jul;2(2):92-96.
- doi: 10.7774/cevr.2013.2.2.92
Herpes zoster and post-herpetic neuralgia deteriorate the quality of life because of severe pain and complications, and cause considerable social and economic burden of disease. In 2012, herpes zoster vaccine... -
- CITED
-
- Close
- SHARE
-
- Close
- Update in varicella vaccination
-
Oh SH
- KMID: 2278579
- Korean J Pediatr.
- 2006 Mar;49(3):229-234.
- doi: 10.3345/kjp.2006.49.3.229
Varicella, which is mostly a benign disease, but also can cause considerable health burden in the community, can be prevented by immunization with live attenuated varicella vaccine. Higher uptake of... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation Methods for the Immunogenicity of Varicella and Zoster Vaccines
-
Park H
- KMID: 1501993
- J Bacteriol Virol.
- 2013 Dec;43(4):253-261.
- doi: 10.4167/jbv.2013.43.4.253
Varicella vaccine has been included in the national immunization program for children since 2005 and zoster vaccine has been released since 2012 in Korea. Even though both varicella and zoster... -
- CITED
-
- Close
- SHARE
-
- Close
- Herpes Zoster Vaccination
-
Kim KH
- KMID: 2074024
- Korean J Pain.
- 2013 Jul;26(3):242-248.
- doi: 10.3344/kjp.2013.26.3.242
Varicella (chickenpox) is a highly contagious airborne disease caused by primary infection with the varicella zoster virus (VZV). Following the resolution of chickenpox, the virus can remain dormant in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimal Timing of Zoster Vaccination After Shingles: A Prospective Study of the Immunogenicity and Safety of Live Zoster Vaccine
-
Lee E, Chun JY, Song KH, Choe PG, Bang JH, Kim ES, Kim HB, Park SW, Kim NJ, Park WB, Oh MD
- KMID: 2429934
- Infect Chemother.
- 2018 Dec;50(4):311-318.
- doi: 10.3947/ic.2018.50.4.311
BACKGROUND: Zoster vaccination is recommended for people with a history of herpes zoster (HZ), but the most effective timing of vaccine administration after zoster illness is unresolved. This prospective observational... -
- CITED
-
- Close
- SHARE
-
- Close
- Comprehensive review and update on herpes zoster
-
Park YM
- KMID: 2409019
- J Korean Med Assoc.
- 2018 Feb;61(2):116-122.
- doi: 10.5124/jkma.2018.61.2.116
Herpes zoster (HZ) is the result of reactivation and multiplication of latent varicella zoster virus that persisted in latent form within the sensory ganglia following an earlier attack of varicella.... -
- CITED
-
- Close
- SHARE
-
- Close
- Modalities in managing postherpetic neuralgia
-
Shrestha M, Chen A
- KMID: 2421514
- Korean J Pain.
- 2018 Oct;31(4):235-243.
- doi: 10.3344/kjp.2018.31.4.235
Postherpetic neuralgia (PHN) is the most troublesome side effect of Herpes Zoster (HZ), which mainly affects the elderly and immunocompromised populations. Despite the current advancement of treatments, PHN persists in... -
- CITED
-
- Close
- SHARE
-
- Close
- General Recommendations and Recent Update in Adult Immunization
-
Yoo S
- KMID: 2247111
- Korean J Health Promot.
- 2012 Mar;12(1):1-12.
BACKGROUNDS: Vaccination is the primary prevention strategy which aims to prevent various vaccine-preventable diseases and its complications. Although immunization practice had been centered on children in Korea, recent epidemic of... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunogenicity and Safety of a Live Attenuated Zoster Vaccine (ZOSTAVAX(TM)) in Korean Adults
-
Choi WS, Choi JH, Choi JY, Eom JS, Kim SI, Pai H, Peck KR, Sohn JW, Cheong HJ
- KMID: 2359986
- J Korean Med Sci.
- 2016 Jan;31(1):13-17.
- doi: 10.3346/jkms.2016.31.1.13
A live attenuated zoster vaccine (ZOSTAVAX(TM), Merck & Co., Inc.) was approved by the Korea Ministry of Food and Drug Safety in 2009. However, the immunogenicity and safety of the... -
- CITED
-
- Close
- SHARE
-
- Close
